ALSUntangled #70: caffeine

References

• Future Reviews [Internet]. ALS Untangled™. 2023. Available at: https://www.alsuntangled.com/future-reviews/. Accessed March 6, 2023.
   Google Scholar
• Ritchie K, Carrière I, de Mendonca A, Portet F, Dartigues JF, Rouaud O, et al. The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology. 2007;69:536–45.
   PubMed Web of Science ®Google Scholar
• Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000;283:2674–9.
   PubMed Web of Science ®Google Scholar
• Xu K, Di Luca DG, Orrú M, Xu Y, Chen JF, Schwarzschild MA. Neuroprotection by caffeine in the MPTP model of Parkinson’s disease and its dependence on adenosine A2A receptors. Neuroscience. 2016;322:129–37.
   PubMed Web of Science ®Google Scholar
• Kolahdouzan M, Hamadeh M. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci Ther. 2017;23:272–90.
   PubMed Web of Science ®Google Scholar
• Stazi M, Lehmann S, Sakib MS, Pena-Centeno T, Büschgens L, Fischer A, et al. Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis. Cell Mol Life Sci. 2021;79:55.
   PubMed Web of Science ®Google Scholar
• Postuma RB, Lang AE, Munhoz RP, Charland K, Pelletier A, Moscovich M, et al. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012;79:651–8.
   PubMed Web of Science ®Google Scholar
• Beghi E, Pupillo E, Messina P, Giussani G, Chio A, Zoccolella S, et al. Coffee and amyotrophic lateral sclerosis: a possible preventive role. Am J Epidemiol. 2011;174:1002–8.
   PubMed Web of Science ®Google Scholar
• Fondell E, O'Reilly ÉI, Fitzgerald KC, Falcone GJ, Kolonel LN, Park Y, et al. Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: results from five cohort studies. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:366–71.
   PubMed Web of Science ®Google Scholar
• Petimar J, O'Reilly É, Adami H-O, van den Brandt PA, Buring J, English DR, et al. Coffee, tea and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studies. Eur J Neurol. 2019;26:468–75.
   PubMed Web of Science ®Google Scholar
• Park H, Yang E. Oxidative stress as a therapeutic target in amyotrophic lateral sclerosis: opportunities and limitations. Diagnostics. 2021;11:1546.
   Web of Science ®Google Scholar
• McCauley M, Baloh R. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715–30.
   PubMed Web of Science ®Google Scholar
• Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 2019;18:211–20.
   PubMed Web of Science ®Google Scholar
• Van den Bosch L, Van Damme P, Bogaert E, Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta. 2006;1762:1068–82.
   PubMed Web of Science ®Google Scholar
• Devasagayam T, Kamat J, Mohan H, Kesavan P. Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta. 1996;1282:63–70.
   PubMed Web of Science ®Google Scholar
• Ullah F, Ali T, Ullah N, Kim M. Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain. Neurochem Int. 2015;90:11–24.
   Web of Science ®Google Scholar
• Seevaratnam R, Raha S, Tarnopolsky MA, Hamadeh MJ. Coffee increases antioxidant enzyme capacity in the brain of male G93A mice, an animal model of amyotrophic lateral sclerosis (ALS). FASEB J. 2009;23:109–6.
   Web of Science ®Google Scholar
• Seevaratnam R, Raha S, Tarnopolsky MA, Hamadeh MJ. Caffeine reduces motor performance and antioxidant enzyme capacity in the brain of female G93A mice, an animal model of amyotrophic lateral sclerosis (ALS). FASEB J. 2009;23:963.3.
   Web of Science ®Google Scholar
• Metro D, Cernaro V, Santoro D, Papa M, Buemi M, Benvenga S, et al. Beneficial effects of oral pure caffeine on oxidative stress. J Clin Transl Endocrinol. 2017;10:22–7.
   PubMedGoogle Scholar
• Brothers HM, Marchalant Y, Wenk GL. Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neurosci Lett. 2010;480:97–100.
   PubMed Web of Science ®Google Scholar
• Madeira MH, Ortin-Martinez A, Nadal-Nícolas F, Ambrósio AF, Vidal-Sanz M, Agudo-Barriuso M, et al. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma. Sci Rep. 2016;6:27532.
   PubMed Web of Science ®Google Scholar
• Boia R, Elvas F, Madeira MH, Aires ID, Rodrigues-Neves AC, Tralhão P, et al. Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage. Cell Death Dis. 2017;8:e3065.
   PubMed Web of Science ®Google Scholar
• Ruggiero M, Calvello R, Porro C, Messina G, Cianciulli A, Panaro M. Neurodegenerative diseases: can caffeine be a powerful ally to weaken neuroinflammation? Int J Mol Sci. 2022;23:12958.
   PubMed Web of Science ®Google Scholar
• Svenningsson P, Hall H, Sedvall G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse. 1997;27:322–35.
   PubMed Web of Science ®Google Scholar
• Mishina M, Ishiwata K. Adenosine receptor PET imaging in human brain. Int Rev Neurobiol. 2014;119:51–69.
   PubMed Web of Science ®Google Scholar
• Rei N, Valente CA, Vaz SH, Farinha-Ferreira M, Ribeiro JA, Sebastião AM. Changes in adenosine receptors and neurotrophic factors in the SOD1G93A mouse model of amyotrophic lateral sclerosis. PLOS One. 2022;17:e0272104.
   PubMed Web of Science ®Google Scholar
• Ng SK, Higashimori H, Tolman M, Yang Y. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis. Exp Neurol. 2015;267:115–22.
   PubMed Web of Science ®Google Scholar
• Potenza RL, Armida M, Ferrante A, Pèzzola A, Matteucci A, Puopolo M, et al. Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis. J Neurosci Res. 2013;91:585–92.
   PubMed Web of Science ®Google Scholar
• Moser JM, Bigini P, Schmitt-John T. The wobbler mouse, an ALS animal model. Mol Genet Genomics. 2013;288:207–29.
   PubMed Web of Science ®Google Scholar
• Zwilling M, Theiss C, Matschke V. Caffeine and NAD(+) improve motor neural integrity of dissociated wobbler cells in vitro. Antioxidants. 2020;9:460.
   Web of Science ®Google Scholar
• Cucovici A, Ivashynka A, Fontana A, Russo S, Mazzini L, Mandrioli J, et al. Coffee and tea consumption impact on amyotrophic lateral sclerosis progression: a multicenter cross-sectional study. Front Neurol. 2021;12:637939.
   PubMed Web of Science ®Google Scholar
• Crayle J, Lutz M, Raymond J, Mehta P, Bedlack R. Study of “ALS reversals”: lifetime environmental exposures (StARLiTE). Amyotroph Lateral Scler Frontotemporal Degen. 2023;24:54–62.
   PubMed Web of Science ®Google Scholar
• Center for Science in the Public Interest [Internet]. Caffeine chart. 2023. Available at: https://www.cspinet.org/caffeine-chart. Accessed March 15, 2023.
   Google Scholar
• FDA [Internet]. Spilling the beans: how much caffeine is too much? 2023. Available at: https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much. Accessed March 15, 2023.
   Google Scholar
• Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr. 2006;46:101–23.
   PubMed Web of Science ®Google Scholar
• Sanderink GJ, Bournique B, Stevens J, Petry M, Martinet M. Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro. J Pharmacol Exp Ther. 1997;282:146572.
   Web of Science ®Google Scholar
• Cappelletti S, Piacentino D, Fineschi V, Frati P, Cipolloni L, Aromatario M. Caffeine-related deaths: manner of deaths and categories at risk. Nutrients. 2018;10:611.
   PubMed Web of Science ®Google Scholar
• Jokela S, Vartiainen A. Caffeine poisoning. Acta Pharmacol Toxicol. 1959;15:331–4.
   PubMedGoogle Scholar
• Amazon [Internet]. Energy supplements. 2023. https://www.amazon.com/Sports-Nutrition-Endurance-Energy-Supplements/b/ref=dp_bc_aui_C_4?ie=UTF8&node=6973678011
   Google Scholar